medline.ch Onkologie Gynäkologische Tumoren

	Integrative bioinformatics approaches for early detection biomarkers in ovarian cancer. Ann Med Surg (Lond) Obeagu EI. PMID: 41675779 [PubMed - as supplied by publisher]
	Thrombopoiesis meets tumorigenesis: unlocking the diagnostic and prognostic potential of platelet indices in breast cancer- a narrative review. Ann Med Surg (Lond) Obeagu EI. PMID: 41675754 [PubMed - as supplied by publisher]
	Radiologic imaging and its current importance in breast cancer management. Front Radiol Dagar N, Sarin M, Yadav P, Thidwar R. PMID: 41675437 [PubMed - in process]
	Immuno-oncological effects of aerobic exercise combined with anti-PD-L1 antibody blockade in a murine breast cancer model. Front Oncol Hekmatikar AA, Agha-Alinejad H, Yousefi-Ahmadipour A, Shamsi MM, Daud DMA. PMID: 41675286 [PubMed - in process]
	BRCA and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR(+)/HER2(-) breast cancer with germline BRCA1/2 mutations: a narrative review. Transl Breast Cancer Res Illia MF, Colucci G, Rodriguez Mignola A, Eiben M, Ballester AM, Zeff N, Paesani F, Crimi G, Von Stecher F, de la Vega M, Perazzo F, Mandó P. PMID: 41675010 [PubMed - in process]
	Chinese expert consensus on endocrine therapy for breast cancer (2026 edition). Transl Breast Cancer Res Yuan Y, Yin Y, Wang S, Liu Y, Yang J, Yan M, Mo X, Pan Y, Wang X, Wang H, Li J, Wang S, Wu J, Song E, Jiang Z, Chinese Consensus Group on Breast Cancer Endocrine Therapy. PMID: 41675009 [PubMed - in process]
	The preliminary study on the effect of PSEN1 on the proliferation and invasion of breast cancer cells. Transl Breast Cancer Res Yang M, Zou JQ, Yang W. PMID: 41675007 [PubMed - in process]
	Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review. Transl Breast Cancer Res Stravodimou A, Voutsadakis IA. PMID: 41675006 [PubMed - in process]
	Real-world efficacy and prognostic factors of CDK4/6 inhibitors in HR(+)/HER2(-) metastatic breast cancer: a multicenter retrospective study from the Dongting Lake region of China. Transl Breast Cancer Res Liu B, Wu T, Lu K, Chen J, Zhou Q, Liu L, Tian C, Hu ZY, Tang Y, Ouyang Q, Xie N. PMID: 41675004 [PubMed - in process]
	Social inequalities in survival among women with breast cancer in southeastern Brazil: a retrospective cohort study. Transl Breast Cancer Res Pessanha RM, Grippa WR, Neto LCBS, Dell'Antonio LS, Dell'Antonio CSDS, Lopes-Júnior LC. PMID: 41675003 [PubMed - in process]
	Comparison of male breast cancer in China and the US: a real-world cohort study. Transl Breast Cancer Res Gao Y, Zhang M, Nie J, Ye G, Sun G, Ma L, Wang H, Jiang Z, Lin Y. PMID: 41675001 [PubMed - in process]
	GNAL-driven calcium signaling reshapes the spatiotemporal immune landscape in ER(+) breast cancer: causal insights and prognostic implications. Transl Cancer Res Zeng J, Tian D, Zhang J, Wang G, Li Y, Yu Y, Tian Y, He J, Shen W, Chen Z. PMID: 41674994 [PubMed - in process]
	Prognostic characteristics, recurrence patterns and survival outcomes of uterine papillary serous carcinoma: a single-centre retrospective cohort study. Transl Cancer Res Conforti J, Sattar A, Zouridis A, Smyth S, Darwish A, Sadeghi N, Abdalla M, Caulfield L, Trent S, Ferrari F, Pappa C, Kehoe S, Addley S, Soleymani Majd H. PMID: 41674960 [PubMed - in process]
	Association of METTL14 expression with prognosis and immunotherapy in breast cancer. Transl Cancer Res Hu J, Wang Z, Lu Y, Wei Z, Dong L, Li Y, Yan H, Tang N. PMID: 41674959 [PubMed - in process]
	A circulating microRNA-based diagnostic model for breast cancer, in which the miR-139-3p/RPA2 axis regulates the sensitivity to DNA-damaging agents. Transl Cancer Res Liu J, Wang Y, Xu X, Zhang Y, Liu X, Liu X, Wang S, Zhao S, Zhang J. PMID: 41674957 [PubMed - in process]
	SanHuang decoction may suppress breast cancer by regulating M1 macrophage polarization via NF-ÎºB signaling pathway: in vitro and in vivo studies. Transl Cancer Res Ying Y, Guo M, Ning Q, Wei Y, Qian J, Cai R. PMID: 41674954 [PubMed - in process]
	Hsa_circ_0001756, a novel biomarker, promotes breast cancer progression via miR-584-5p/TRAF6 signaling axis. Transl Cancer Res Wu JY, Wu XX, Shi LY, Wang LX, Cao Y, Shao XJ, Wang B, Yang H. PMID: 41674950 [PubMed - in process]
	Role of TRAIL in mediating the effect of lipidome on breast cancer: a Mendelian randomization study. Transl Cancer Res Wang X, Yang T, Wang X, Hu K, Hu J, Shi H, Jing J, Luo T. PMID: 41674936 [PubMed - in process]
	Comparative Evaluation of Infrared Thermography and Mammography in the Detection of Breast Cancer. Cureus S H, Das SK, Patel Mc S, Naik D, K S, M H G, Esther S, Dhanekula SCV. PMID: 41674768 [PubMed]
	Leveraging a chromosomal instability-based signature to predict the prognosis and immune landscape of breast cancer. Genes Dis Wang H, Dai H, Wang Y, Wu Q, Zhu M, Yin W, Lu J. PMID: 41674664 [PubMed]

Artikel 1 - 20 / 324293

Seite 1 von 16215

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung